
Investors are treating the $39,800 pancreatic cancer pill as evidence that its developer could build a broader cancer drug platform. A company shareholder described the development as a possible step toward a post-cancer era.
6:33 PMFortune28 stories from 9 sources
Supporting Articles

Investors are treating the $39,800 pancreatic cancer pill as evidence that its developer could build a broader cancer drug platform. A company shareholder described the development as a possible step toward a post-cancer era.
6:33 PMFortune
US regulators approved daraxonrasib, a new treatment for pancreatic cancer that experts have described as a potential game changer. The drug offers a new option for patients with one of the deadliest major cancers.
6:02 PMBBC
The FDA approved Revolution Medicines' once-daily pill for targeted treatment of pancreatic cancer. The drug blocks several forms of the RAS protein, a driver of tumor growth in many pancreatic cancers.
11:51 AMCNBC
A fire on the third floor of Islamabad’s largest hospital killed 14 newborns. The deaths occurred in the hospital’s neonatal care facilities.
2:30 PMThe New York Times
Witnesses say the nursery door was locked when a fire killed 14 babies at a Pakistan hospital. The hospital disputes that account, saying the door was staffed by security guards to protect the infants.
10:42 AMBBC
Kennedy has used social media to blame others for falling vaccination rates while downplaying the risks of measles. His posts come as measles deaths are being reported.
2:17 PMStat News
Drugmakers are advancing treatments for high lipoprotein(a), or Lp(a), a common inherited cardiovascular risk that existing cholesterol medicines do not adequately address. Several products could soon reach the market, creating a potentially multibillion-dollar treatment category.
4:30 AMStat News
Health care costs are rising even for large employers, while other developments include two measles deaths and debate over the profit motive in women’s health. The items point to pressure across both health financing and public health.
9:29 AMStat News
About 14% of U.S. employers have already dropped or plan to drop coverage for GLP-1 drugs in 2027 as health care costs rise. The roundup also covers GSK’s shingles vaccine and other pharmaceutical news.
9:09 AMStat News
A mosquito believed to have arrived on a plane caused malaria infections among workers at Frankfurt airport, with reported deaths and four infected employees receiving hospital treatment. Authorities have deployed mosquito traps at the hub.
3:21 PMAl Jazeera
An Oxford-led study found that people who received the newer shingles vaccine had lower rates of heart disease, alongside previously reported reductions in dementia risk. Researchers describe the findings as evidence that the vaccine may protect beyond shingles prevention.
5:00 AMStat News
Summary
Investors are treating the $39,800 pancreatic cancer pill as evidence that its developer could build a broader cancer drug platform. A company shareholder described the development as a possible step toward a post-cancer era.
The market is valuing the drug for more than its first indication, betting that its
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The drug's price and platform potential could shape both cancer investment and the debate over who can afford breakthrough treatments.

Summary
US regulators approved daraxonrasib, a new treatment for pancreatic cancer that experts have described as a potential game changer. The drug offers a new option for patients with one of the deadliest major cancers.
The approval expands treatment options in a disease where progress has been limited and survival
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A new pancreatic cancer treatment could shift care in a disease that has long offered patients few effective options.
2 stories · 2 sources

Summary
The FDA approved Revolution Medicines' once-daily pill for targeted treatment of pancreatic cancer. The drug blocks several forms of the RAS protein, a driver of tumor growth in many pancreatic cancers.
The approval gives oncologists an oral treatment aimed at a central biological driver in a
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Targeting RAS could open a new treatment path for some pancreatic cancer patients, a group long underserved by precision oncology.

Summary
A fire on the third floor of Islamabad’s largest hospital killed 14 newborns. The deaths occurred in the hospital’s neonatal care facilities.
The incident exposes the extreme vulnerability of newborns when fire safety and emergency evacuation systems
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A deadly fire in a neonatal unit shows how infrastructure failures can turn routine hospital care into a mass-casualty event.
4 stories · 3 sources

Summary
Witnesses say the nursery door was locked when a fire killed 14 babies at a Pakistan hospital. The hospital disputes that account, saying the door was staffed by security guards to protect the infants.
The dispute over the door is now central to determining whether access controls delayed evacuation.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The conflicting accounts could determine whether the tragedy reflects an unavoidable fire or a preventable failure of hospital safety.

Summary
Kennedy has used social media to blame others for falling vaccination rates while downplaying the risks of measles. His posts come as measles deaths are being reported.
The health secretary's messaging undermines public-health efforts during an active measles threat. By shifting blame
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Federal vaccine messaging can directly affect uptake, outbreak control, and public confidence in basic disease prevention.

Summary
Drugmakers are advancing treatments for high lipoprotein(a), or Lp(a), a common inherited cardiovascular risk that existing cholesterol medicines do not adequately address. Several products could soon reach the market, creating a potentially multibillion-dollar treatment category.
The decisive change is the move from measuring Lp(a) as an under-treated risk factor to
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A new drug class could reshape preventive cardiology and create a major commercial market.

Summary
Health care costs are rising even for large employers, while other developments include two measles deaths and debate over the profit motive in women’s health. The items point to pressure across both health financing and public health.
Rising costs at large companies show that scale is not protecting employers from broader medical
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Higher spending is becoming a structural problem for employers, patients, and public health systems rather than a temporary budget shock.

Summary
About 14% of U.S. employers have already dropped or plan to drop coverage for GLP-1 drugs in 2027 as health care costs rise. The roundup also covers GSK’s shingles vaccine and other pharmaceutical news.
Employers are beginning to limit GLP-1 coverage because demand and treatment costs are straining benefit
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
GLP-1 access is moving from a clinical question to a major test of who pays for high-demand medicines.

Summary
A mosquito believed to have arrived on a plane caused malaria infections among workers at Frankfurt airport, with reported deaths and four infected employees receiving hospital treatment. Authorities have deployed mosquito traps at the hub.
The incident shows how international air travel can move disease vectors into places where malaria
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Imported vectors can create serious health risks far from endemic regions and expose gaps in airport disease-control systems.
2 stories · 2 sources

Summary
An Oxford-led study found that people who received the newer shingles vaccine had lower rates of heart disease, alongside previously reported reductions in dementia risk. Researchers describe the findings as evidence that the vaccine may protect beyond shingles prevention.
The key shift is that a vaccine already used to prevent shingles may also reduce
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A routine vaccine could eventually offer broader protection against two major causes of illness and death.
A curated list of other prominent stories from this day.

The World Health Organization declared Uganda free of Ebola after 42 days without a new transmission. The announcement comes as Ebola cases continue to rise in the Democratic Republic of the Congo.
7:46 PMAl Jazeera
Busy Philipps said doctors removed a malignant brain tumor after a precautionary full-body MRI detected it. She disclosed the diagnosis and surgery weeks before she was scheduled to begin filming her new CBS show.
1:22 PMVariety
Citadel Care Centers has begun construction on a skilled nursing facility in North Miami Beach after securing a $50.9 million loan from PNC Bank. The financing covers a 3.2-acre, full-block site near Northeast 167th Street, roughly three miles south of Aventura.
12:55 PMHousing Wire
Cigna AI chief Katya Andresen says the company is investing in AI to make healthcare more conversational, proactive, and personalized for its 185 million customers. The effort also aims to reduce costs and address broader operational problems in healthcare.
12:12 PMFortune
New studies find that coronary artery calcium scans help guide statin decisions in only a small share of borderline cases. The scans are increasingly used to refine cardiovascular risk assessments when the treatment decision is uncertain.
11:00 AMStat News
The report previews upcoming data on a new class of cardiovascular drugs and also covers GSK’s shingles vaccine, investment in women’s health, and other biotechnology developments.
10:32 AMStat News
Insitro CEO Daphne Koller discusses how artificial intelligence could improve drug discovery and accelerate clinical trials. The conversation is part of a broader roundup of developments in health care AI.
9:46 AMStat News
Researchers used Britain’s postwar sugar rationing as a natural experiment and found that greater rationing during the first 1,000 days was associated with lower cancer rates and slower biological aging decades later. Those exposed to more rationing also reported lower sugar intake and healthier diets around age 50.
7:30 AMScienceDaily
In rats with Type 1 diabetes, curcumin reduced inflammation, improved cellular signaling, and restored blood vessel health toward levels seen in nondiabetic animals.
6:49 AMScienceDaily
A French court recognized former Air France stewardess Sophie Lainault's breast cancer as an occupational disease linked to radiation exposure during flight work.
6:29 AMBBC
The essay examines how legal access to medical aid in dying changes the ethical landscape for patients facing severe illness and suffering. It argues that availability of the option can alter the meaning and burden of choosing to continue living.
4:30 AMStat News
Women’s health experts argue that stronger investment in conditions such as endometriosis, osteoporosis, and autoimmune disease requires presenting their commercial potential more forcefully. The approach treats unmet medical needs as opportunities for drug development rather than only as equity concerns.
4:30 AMStat News
Summary
The World Health Organization declared Uganda free of Ebola after 42 days without a new transmission. The announcement comes as Ebola cases continue to rise in the Democratic Republic of the Congo.
Uganda has moved from active outbreak response to surveillance and follow-up care, reducing immediate pressure
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Uganda's containment shows Ebola can be stopped, but rising cases nearby leave East Africa vulnerable to renewed transmission.

Summary
Busy Philipps said doctors removed a malignant brain tumor after a precautionary full-body MRI detected it. She disclosed the diagnosis and surgery weeks before she was scheduled to begin filming her new CBS show.
The case shows how incidental imaging can uncover serious disease, but it does not establish
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A personal survival story may increase interest in whole-body screening even as clinicians weigh its uncertain benefits against downstream harms.

Summary
Citadel Care Centers has begun construction on a skilled nursing facility in North Miami Beach after securing a $50.9 million loan from PNC Bank. The financing covers a 3.2-acre, full-block site near Northeast 167th Street, roughly three miles south of Aventura.
The loan moves the project from acquisition and planning into construction, adding a sizable new
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The project adds potential nursing capacity in a growing South Florida healthcare market and signals continued lender appetite for specialized care facilities.

Summary
Cigna AI chief Katya Andresen says the company is investing in AI to make healthcare more conversational, proactive, and personalized for its 185 million customers. The effort also aims to reduce costs and address broader operational problems in healthcare.
Cigna is positioning AI as an infrastructure layer across a huge customer base, not merely
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Healthcare AI will be judged less by novelty than by whether it lowers friction and costs at population scale.

Summary
New studies find that coronary artery calcium scans help guide statin decisions in only a small share of borderline cases. The scans are increasingly used to refine cardiovascular risk assessments when the treatment decision is uncertain.
The evidence narrows, rather than expands, the scan's role: calcium scoring may change treatment for
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Calcium scans are a selective decision aid, not a routine substitute for established cardiovascular risk assessment.

Summary
The report previews upcoming data on a new class of cardiovascular drugs and also covers GSK’s shingles vaccine, investment in women’s health, and other biotechnology developments.
The forthcoming cardiovascular results could clarify whether the drug class offers meaningful clinical benefits beyond
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
New cardiovascular data could reshape treatment decisions in a large market if the drugs improve outcomes rather than merely biomarkers.

Summary
Insitro CEO Daphne Koller discusses how artificial intelligence could improve drug discovery and accelerate clinical trials. The conversation is part of a broader roundup of developments in health care AI.
The central opportunity is to reduce the time and cost of moving promising compounds into
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
AI’s value in medicine will be measured by whether it shortens the path from discovery to safe, effective treatment.

Summary
Researchers used Britain’s postwar sugar rationing as a natural experiment and found that greater rationing during the first 1,000 days was associated with lower cancer rates and slower biological aging decades later. Those exposed to more rationing also reported lower sugar intake and healthier diets around age 50.
The study suggests that nutrition early in life may shape disease risk and aging across
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Early dietary policy could influence health outcomes far beyond childhood, but the evidence does not yet define a precise intervention.

Summary
In rats with Type 1 diabetes, curcumin reduced inflammation, improved cellular signaling, and restored blood vessel health toward levels seen in nondiabetic animals.
The results identify vascular inflammation as a potential target for reducing diabetes-related cardiovascular damage. Curcumin
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If confirmed, the compound could complement glucose control by addressing the blood vessel damage that drives long-term diabetes complications.

Summary
A French court recognized former Air France stewardess Sophie Lainault's breast cancer as an occupational disease linked to radiation exposure during flight work.
The ruling gives legal weight to the claim that repeated exposure to cosmic radiation can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The decision may expand the obligations airlines face toward workers exposed to radiation at altitude.

Summary
The essay examines how legal access to medical aid in dying changes the ethical landscape for patients facing severe illness and suffering. It argues that availability of the option can alter the meaning and burden of choosing to continue living.
The central shift is from debating aid in dying as a theoretical prohibition to confronting
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Legal access changes not only end-of-life options but also the conditions under which patients make those decisions.

Summary
Women’s health experts argue that stronger investment in conditions such as endometriosis, osteoporosis, and autoimmune disease requires presenting their commercial potential more forcefully. The approach treats unmet medical needs as opportunities for drug development rather than only as equity concerns.
The proposed shift is to make profitability central to the case for funding women’s health
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The strategy could unlock investment, but market logic will shape which women’s health problems receive solutions.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!